GGrantIndex
← Leaderboards

Mark H Pollack

Massachusetts General Hospital

$7,343,315
Attributed
$7,343,315
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY200516
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$7,343,315 · 7

By mechanism

R01$5,966,495 · 5
R34$1,376,820 · 2

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Placebos

Research focus

PlacebosSafetyRelative (Related Person)Public Health Medicine (Field)SiteAnxiety DisordersBaseSeveritiesAnxietySocialRandomizedAgonistFrightPsychosocialProgramsAcuteTranslational ResearchExtinction (Psychology)CycloserinePilot ProjectsSuccessMediatingLeadResponse

Grant awards (28)

Dose Timing of D-cycloserine to Augment CBT for Social Anxiety Disorder$232,500
R34 · FY2016 · MH · contact PI
Dose Timing of D-cycloserine to Augment CBT for Social Anxiety Disorder$232,500
R34 · FY2015 · MH · contact PI
Dose Timing of D-cycloserine to Augment CBT for Social Anxiety Disorder$232,500
R34 · FY2014 · MH · contact PI
Eszopiclone for the Treatment of PTSD$220,320
R34 · FY2013 · MH · contact PI
Eszopiclone for the Treatment of PTSD$229,500
R34 · FY2012 · MH · contact PI
3/3-Exposure D-Cycloserine Enhancement and Genetic Modulators in Panic Disorder$198,468
R01 · FY2012 · MH · contact PI
Eszopiclone for the Treatment of PTSD$229,500
R34 · FY2011 · MH · contact PI
3/3-Exposure D-Cycloserine Enhancement and Genetic Modulators in Panic Disorder$225,982
R01 · FY2011 · MH · contact PI
3/3-Exposure D-Cycloserine Enhancement and Genetic Modulators in Panic Disorder$49,999
R01 · FY2011 · MH · contact PI
D-Cycloserine Enhancement of Exposure in Social Phobia$395,347
R01 · FY2010 · MH · contact PI
3/3-Exposure D-Cycloserine Enhancement and Genetic Modulators in Panic Disorder$238,950
R01 · FY2010 · MH · contact PI
D-Cycloserine Enhancement of Exposure in Social Phobia$140,680
R01 · FY2010 · MH · contact PI
D-Cycloserine Enhancement of Exposure in Social Phobia$27,920
R01 · FY2010 · MH · contact PI
D-Cycloserine Enhancement of Exposure in Social Phobia$403,539
R01 · FY2009 · MH · contact PI
Improving Outcomes in Pharmacotherapy of Social Phobia$319,299
R01 · FY2009 · MH · contact PI
3/3-Exposure D-Cycloserine Enhancement and Genetic Modulators in Panic Disorder$277,988
R01 · FY2009 · MH · contact PI
D-Cycloserine Enhancement of Exposure in Social Phobia$392,979
R01 · FY2008 · MH · contact PI
Improving Outcomes in Pharmacotherapy of Social Phobia$319,299
R01 · FY2008 · MH · contact PI
3/3-Exposure D-Cycloserine Enhancement and Genetic Modulators in Panic Disorder$276,413
R01 · FY2008 · MH · contact PI
D-Cycloserine Enhancement of Exposure in Social Phobia$422,034
R01 · FY2007 · MH · contact PI
Improving Outcomes in Pharmacotherapy of Social Phobia$328,833
R01 · FY2007 · MH · contact PI
Improving Outcomes in Pharmacotherapy of Social Phobia$338,655
R01 · FY2006 · MH · contact PI
Improving Outcomes in Pharmacotherapy of Social Phobia$346,804
R01 · FY2005 · MH
Impact of Trauma of Terroist Attack on Bipolar Patients$1
R01 · FY2003 · MH
MR SPECTROSCOPIC IMAGING DURING METHADONE MAINTENANCE$350,487
R01 · FY2002 · DA
Impact of Trauma of Terroist Attack on Bipolar Patients$259,499
R01 · FY2002 · MH
MR SPECTROSCOPIC IMAGING DURING METHADONE MAINTENANCE$333,204
R01 · FY2001 · DA
MR SPECTROSCOPIC IMAGING DURING METHADONE MAINTENANCE$320,115
R01 · FY2000 · DA